Analysis on repetitive reporting of hepatitis B in Fujian province, 2016-2020.
10.3760/cma.j.cn112338-20210630-00509
- VernacularTitle:福建省2016-2020年乙型肝炎疫情重复报告情况分析
- Author:
Zhong Hang XIE
1
;
Jia Wei LIN
1
;
Wen Long HUANG
1
;
Han Song ZHU
1
;
Ling Fang LI
1
;
Wu CHEN
1
;
Jian Ming OU
1
Author Information
1. Emergency Management and Epidemic Management Office, Fujian Provincial Center for Disease Control and Prevention/Fujian Provincial Key Laboratory of Zoonosis Research, Fuzhou 350001, China.
- Publication Type:Journal Article
- MeSH:
China/epidemiology*;
Data Collection;
Hepatitis B/epidemiology*;
Humans;
Incidence;
Software
- From:
Chinese Journal of Epidemiology
2022;43(3):343-347
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To analyze the repetitive reporting of hepatitis B in Fujian province during 2016-2020, and provide evidence for the improvement of hepatitis B surveillance. Methods: The reporting cards from the China Information System for Disease Control and Prevention were collected and divided into repetitive reporting cards and non-repetitive reporting cards from the report cards collected according to the valid ID number on the cards, and the proportion of repetitive report cards and related factors were analyzed by using software SAS 9.4. Results: A total of 314 551 hepatitis B reporting cards were submitted in Fujian from 2016 to 2020, in which 90.93% (286 020/314 551) were included in the analysis. The repetitive reporting cards accounted for 10.48% (29 982/286 020). The annual proportion of the repetitive reporting cards from 2016 to 2020 was between 2.98% and 3.71%, showing an overall increasing trend year by year (Z=2.26, P=0.024). The proportions of the repetitive reporting cards in 1-5 years were 3.17%, 5.40%, 7.74%, 9.27% and 10.48%, respectively, showing an increase trend with year (Z=128.16, P<0.001). The proportions of the repetitive reporting cards in 10 areas of Fujian ranged from 5.44% to 13.48% with significant difference (χ2=2 050.41, P<0.001) and increased with the increase of reported incidence of hepatitis B (Z=26.92, P<0.001). There were significant differences in relationships between repetitive reporting proportion and sex, age and type of the cases between the areas with high incidence and low incidence of hepatitis B. Conclusions: The reported incidence of hepatitis B was seriously affected by the repetitive reporting in Fujian from 2016 to 2020. A cross-year and cross-area surveillance mechanism for hepatitis B should be established and targeted measures should be taken to strengthen the control of the repetitive reporting and improve the surveillance for hepatitis B.
